COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,802 Articles (22,527 medRxiv, 8,275 bioRxiv)

Most recent first Previous |  Page 1916: Articles 19151-19160  | Next

A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques.
Baisa, G., Rancour, D., Mansfield, K., Burns, M., Martin, L., Cunha, D., Fischer, J., Muecksch, F., Hatziioannou, T., Bieniasz, P., Schomburg, F., Luke, K.
10.1101/2020.12.20.422693 — Posted: 2020-12-21
Immunological and pathological outcomes of SARS-CoV-2 challenge after formalin-inactivated vaccine immunisation of ferrets and rhesus macaques
Bewley, K. R., Gooch, K. E. R., Thomas, K. M., Longet, S. R., Wiblin, N., Hunter, L., Chan, K., Brown, P., Russell, R. A., Ho, C., Slack, G., Humphries, H. E., Alden, L., Allen, L., Aram, M., Baker, N., Brunt, E., Cobb, R., Fotheringham, S., Harris, D., Kennard, C., Leung, S., Ryan, K. A., Tolley, H., Wand, N., White, A., Sibley, L., Sarfas, C., Pearson, G., Rayner, E., Xue, X., Lambe, T., Charlton, S., Gilbert, S. C., Sattentau, Q., Gleeson, F., Hall, Y., Funnell, S. G. P., Sharpe, S., Salguero, F. J., Gorringe, A. R., Carroll, M.
10.1101/2020.12.21.423746 — Posted: 2020-12-21
Minimizing exposure to respiratory droplets, 'jet riders' and aerosols in air-conditioned hospital rooms by a 'Shield-and-Sink' strategy
Hunziker, P.
10.1101/2020.12.08.20233056 — Posted: 2020-12-21
SARS-CoV-2 escapes CD8 T cell surveillance via mutations in MHC-I restricted epitopes
Agerer, B., Koblischke, M., Gudipati, V., Smyth, M., Popa, A., Genger, J.-W., Endler, L., Florian, D. M., Muehlgrabner, V., Lercher, A., Gattinger, P., Torralba-Gombau, R., Penz, T., Fae, I., Wenda, S., Traungott, M., Walder, G., Fischer, G., Hoepler, W., Pawelka, E., Zoufaly, A., Valenta, R., Bock, C., Huppa, J. B., Aberle, J. H., Bergthaler, A.
10.1101/2020.12.18.423507 — Posted: 2020-12-20
SARS-CoV-2 protein ORF3a is pathogenic in Drosophila and causes phenotypes associated with COVID-19 post-viral syndrome
Yang, S., Tian, M., Johnson, A. N.
10.1101/2020.12.20.423533 — Posted: 2020-12-20
Identification of NPC1 as a novel SARS-CoV-2 intracellular target
Garcia-Dorival, I., Cuesta-Geijo, M. A., Barrado-Gil, L., Galindo, I., Urquiza, J., Del Puerto, A., Gil, C., Campillo, N., Martinez, A., Alonso, C.
10.1101/2020.12.19.423584 — Posted: 2020-12-20
Furin cleaves SARS-CoV-2 spike-glycoprotein at S1/S2 and S2'for viral fusion/entry: indirect role for TMPRSS2
Essalmani, R., Jain, J., Susan-Resiga, D., Andreo, U., Evagelidis, A., Derbali, R. M., Huynh, D., Dallaire, F., Laporte, M., Delpal, A., Sutto-Ortiz, P., Coutard, B., Mapa, C., Wilcoxen, K., Decroly, E., Pham, T., Cohen, E. A., Seidah, N. G. G.
10.1101/2020.12.18.423106 — Posted: 2020-12-20
Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic carriers and symptomatic/ presymptomatic COVID-19 patients
Chen, Y., Li, P., Ding, Y., Liu, M., Liu, L., Yi, B., Wu, T., Dong, H., Lao, X., Ding, K., Wang, H., Zhang, D., Tan, X., Wang, Z., Xu, G., Cao, G.
10.1101/2020.12.18.20248447 — Posted: 2020-12-20
Common variants at 21q22.3 locus influence MX1 gene expression and susceptibility to severe COVID-19
Andolfo, I., Russo, R., Lasorsa, A. V., Cantalupo, S., Rosato, B. E., Bonfiglio, F., Frisso, G., Abete, P., Cassese, G. M., Servillo, G., Esposito, G., Gentile, I., Piscopo, C., Villani, R., Fiorentino, G., Cerino, P., Buonerba, C., Pierri, B., Zollo, M., Iolascon, A., Capasso, M.
10.1101/2020.12.18.20248470 — Posted: 2020-12-20
Glycyrrhizin effectively neutralizes SARS-CoV-2 in vitro by inhibiting the viral main protease
van de Sand, L., Bormann, M., Alt, M., Schipper, L., Heilingloh, C. S., Todt, D., Dittmer, U., Elsner, C., Witzke, O., Krawczyk, A.
10.1101/2020.12.18.423104 — Posted: 2020-12-20 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).